Qiagen Stock Today


USD 44.00  0.41  0.94%   

Market Performance
0 of 100
Odds Of Distress
Less than 1
Qiagen NV is selling for 44.00 as of the 7th of October 2022. This is a 0.94 percent up since the beginning of the trading day. The stock's open price was 43.59. Qiagen NV has a very small chance of experiencing financial distress in the next few years, but has generated negative returns over the last 90 days. Equity ratings for Qiagen NV are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 7th of September 2022 and ending today, the 7th of October 2022. Click here to learn more.
QIAGEN N.V. offers sample to insight solutions that transform biological materials into molecular insights worldwide. The company was founded in 1986 and is headquartered in Venlo, the Netherlands. Qiagen NV operates under Diagnostics Research classification in the United States and is traded on New York Stock Exchange. The company has 227.34 M outstanding shares of which 4.54 M shares are at this time shorted by private and institutional investors with about 4.21 trading days to cover. More on Qiagen NV

Moving together with Qiagen NV

+0.83INTCIntel Corp TrendingPairCorr
Follow Valuation Odds of Bankruptcy
Check how we calculate scores

Qiagen NV Stock Highlights

Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Qiagen NV's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Qiagen NV or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
Qiagen NV generated a negative expected return over the last 90 days
Qiagen NV is unlikely to experience financial distress in the next 2 years
About 74.0% of the company shares are owned by institutional investors
Latest headline from simplywall.st: Calculating The Fair Value Of Qiagen N.V. - Simply Wall St
CEO and Managing DirectorPeer Schatz
Thematic IdeaESG Investing (view all)
Average Analyst Recommendation
Analysts covering Qiagen NV report their recommendations after researching Qiagen NV's financial statements, talking to executives and customers, or listening in on Qiagen NV's conference calls. The current trade recommendation is based on an ongoing consensus estimate among financial analysts covering Qiagen NV. The Qiagen consensus assessment is calculated by taking the average forecast from all of the analysts covering Qiagen NV.
Macroaxis Advice
Unlike general analyst consensus, Macroaxis buy hold or sell recommendation is provided in the context of your current investment horizon and risk tolerance. The advice algorithm takes into account all of Qiagen NV's available fundamental, technical, and predictive indicators. Your current horizon is 90 days - details
Strong HoldOvervalued
Qiagen NV (QGEN) is traded on New York Stock Exchange in USA and employs 6,100 people. The company currently falls under 'Mid-Cap' category with current market capitalization of 10 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Qiagen NV's market, we take the total number of its shares issued and multiply it by Qiagen NV's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and these looking for more risk prefer small-cap and mid-cap equities. Qiagen NV conducts business under Healthcare sector and is part of Diagnostics & Research industry. The entity has 227.34 M outstanding shares of which 4.54 M shares are at this time shorted by private and institutional investors with about 4.21 trading days to cover. Qiagen NV currently holds about 1.31 B in cash with 733.34 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 5.76.
Check Qiagen NV Probability Of Bankruptcy
Qiagen NV has a total of 227.34 Million outstanding shares. The majority of Qiagen NV outstanding shares are owned by third-party entities. These institutional holders are usually referred to as non-private investors looking to secure positions in Qiagen NV to benefit from reduced commissions. Consequently, institutional investors are subject to a different set of regulations than regular investors in Qiagen NV. Please pay attention to any change in the institutional holdings of Qiagen NV as this could imply that something significant has changed or about to change at the company. Note that regardless of who owns the company, if the true value of the entity is less than the market is willing to pay for it, you may not be able to generate positive returns over time.

Ownership Allocation (%)

Check Qiagen Ownership Details

Qiagen Stock Price Odds Analysis

Proceeding from a normal probability distribution, the odds of Qiagen NV jumping above the current price in 90 days from now is about 81.15%. The Qiagen NV probability density function shows the probability of Qiagen NV stock to fall within a particular range of prices over 90 days. Given the investment horizon of 90 days Qiagen NV has a beta of 0.8272 indicating as returns on the market go up, Qiagen NV average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Qiagen NV will be expected to be much smaller as well. Additionally, the company has a negative alpha, implying that the risk taken by holding this instrument is not justified. Qiagen NV is significantly underperforming DOW.
  Odds Below 44.0HorizonTargetOdds Above 44.0
18.70%90 days
Based on a normal probability distribution, the odds of Qiagen NV to move above the current price in 90 days from now is about 81.15 (This Qiagen NV probability density function shows the probability of Qiagen Stock to fall within a particular range of prices over 90 days) .

Qiagen Stock Institutional Holders

Institutional Holdings refers to the ownership stake in Qiagen NV that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Qiagen NV's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Qiagen NV's value.
InstituionSecurity TypeTotal SharesValue
Massachusetts Financial Services CoCommon Shares20.4 M964.4 M
Vanguard Group IncCommon Shares8.1 M384.1 M
View Qiagen NV Diagnostics

Qiagen NV Risk Profiles

Investors will always prefer to have the highest possible return on investment while minimizing volatility. Qiagen NV market risk premium is the additional return an investor will receive from holding Qiagen NV long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Qiagen NV. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Although Qiagen NV's alpha and beta are two of the key measurements used to evaluate Qiagen NV's performance over the market, the standard measures of volatility play an important role as well.

Qiagen Stock Against Markets

Picking the right benchmark for Qiagen NV stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Qiagen NV stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Qiagen NV is critical whether you are bullish or bearish towards Qiagen NV at a given time.

Be your own money manager

Our tools can tell you how much better you can do entering a position in Qiagen NV without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Headlines Timeline Now


Headlines Timeline

Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
All  Next Launch Module

Qiagen NV Corporate Directors

Qiagen NV corporate directors refer to members of a Qiagen NV board of directors. The board of directors generally takes responsibility for the Qiagen NV's affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of Qiagen NV's board members must vote for the resolution. The Qiagen NV board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.
Manfred Karobath - Independent Supervisory DirectorProfile
Hakan Bjorklund - Supervisory Board DirectorProfile
Werner Brandt - Independent Supervisory DirectorProfile
Roland Sackers - Managing Director, Chief Financial Officer, Member of the Executive CommitteeProfile

Invested in Qiagen NV?

The danger of trading Qiagen NV is mainly related to its market volatility and company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Qiagen NV is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Qiagen NV. The Shape ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Qiagen NV is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
Please see Your Equity Center. Note that the Qiagen NV information on this page should be used as a complementary analysis to other Qiagen NV's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try CEO Directory module to screen CEOs from public companies around the world.

Complementary Tools for Qiagen Stock analysis

When running Qiagen NV price analysis, check to measure Qiagen NV's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Qiagen NV is operating at the current time. Most of Qiagen NV's value examination focuses on studying past and present price action to predict the probability of Qiagen NV's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Qiagen NV's price. Additionally, you may evaluate how the addition of Qiagen NV to your portfolios can decrease your overall portfolio volatility.
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
CEO Directory
Screen CEOs from public companies around the world
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Global Correlations
Find global opportunities by holding instruments from different markets
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Is Qiagen NV's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Qiagen NV. If investors know Qiagen will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Qiagen NV listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Qiagen NV is measured differently than its book value, which is the value of Qiagen that is recorded on the company's balance sheet. Investors also form their own opinion of Qiagen NV's value that differs from its market value or its book value, called intrinsic value, which is Qiagen NV's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Qiagen NV's market value can be influenced by many factors that don't directly affect Qiagen NV's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Qiagen NV's value and its price as these two are different measures arrived at by different means. Investors typically determine Qiagen NV value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Qiagen NV's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.